These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 28094665)
21. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma. Nishiyama Y; Yamamoto Y; Fukunaga K; Kimura N; Miki A; Sasakawa Y; Wakabayashi H; Satoh K; Ohkawa M J Nucl Med; 2006 Apr; 47(4):633-8. PubMed ID: 16595497 [TBL] [Abstract][Full Text] [Related]
22. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies. Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582 [TBL] [Abstract][Full Text] [Related]
23. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma. Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646 [TBL] [Abstract][Full Text] [Related]
24. 18F-FDG PET of common enhancing malignant brain tumors. Kosaka N; Tsuchida T; Uematsu H; Kimura H; Okazawa H; Itoh H AJR Am J Roentgenol; 2008 Jun; 190(6):W365-9. PubMed ID: 18492879 [TBL] [Abstract][Full Text] [Related]
25. Impact of animal handling on the results of 18F-FDG PET studies in mice. Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310 [TBL] [Abstract][Full Text] [Related]
27. Defining a radiotherapy target with positron emission tomography. Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800 [TBL] [Abstract][Full Text] [Related]
28. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model. Song SL; Liu JJ; Huang G; Wang ZH; Song YY; Sun XG; Chen T J Nucl Med; 2008 Feb; 49(2):303-9. PubMed ID: 18199614 [TBL] [Abstract][Full Text] [Related]
29. Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study. Jena A; Taneja S; Goel R; Renjen P; Negi P Eur J Radiol; 2014 Jul; 83(7):1269-1274. PubMed ID: 24813529 [TBL] [Abstract][Full Text] [Related]
30. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma. Qi Q; Fox MS; Lim H; Bartha R; Scholl TJ; Hoffman L; Lee TY; Thiessen JD Mol Imaging Biol; 2021 Aug; 23(4):516-526. PubMed ID: 33534038 [TBL] [Abstract][Full Text] [Related]
31. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP). Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819 [TBL] [Abstract][Full Text] [Related]
32. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size. Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206 [TBL] [Abstract][Full Text] [Related]